UV-spectrophotometric method for estimation of telmisartan in bulk and tablet dosage form

International Journal of ChemTech Research

Volumn 3, Issue 2, 2011, Pages 657-660

  Pandey, Ajit ^a   Sawarkar, H ^a   Singh, Mukesh ^b   Kashyap, P ^a   Ghosh, Priyanka ^a  

^a Shri Rawatpura Sarkar Institute of Pharmacy   (India)

^b RUNGTA COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

0.1N NaOH; Telmisartan; Uv spectrophotometric

Indexed keywords

TELMISARTAN;

ARTICLE; CALIBRATION; DRUG DETERMINATION; DRUG STABILITY; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 79955789173     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Budavari S., O'Neil M.J., Smith A., Heckelman P.E. Ed. The Merck Index, MaryAdele 13th edition published by Merck Research Lab, Division of Merck and Co.,White house station, NJ, USA, 2001, 148.
2. Balt J.C., Mathy M.J., Nap A., Pfaffendorf M., Van Zwieten P.A., Effect of the AT1- receptor antagonists Losartan, Irbesartan and Telmisartan on angiotensin II induced facilitation of sympathetic neurotransmission in the rat mesenteric artery., JcardiovascPharmacol., 2001 July; 38(1):141-18.
3. Karlberg B.E., Lins L.E., Hermanson K: Efficacy and Safety of Telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. J Hypertens. 1999 February; 17(2):293-302.
4. Weber M., The Telmisartan programme of research to show Telmisartan End organ protection (Protection) programme. JHypertens 2003; 21(6):S37-S46.
5. Bankey S., Tapadiya G.G., Saboo S.S., Bindaiya S., Jain Deepti and Khadbadi S.S., 2009., Simultaneous determination of Ramipril, Hydrochloride and Telmisartan byspectrophotometry., International Journal of ChemTech Research.,1(2): 183-188.
6. Hempen Christel., Glasle Schwarz Liane., Kunz Ulrich and Karst Uwe., 2006., Determination of Telmisartan in human blood plasma: part 2: Liquid chromatographytandem mass spectrometry method development., comparison to Immunoassay and Pharmacokinetics study., AnalyticaChimica Acta., 560 (1-2):35-40.
7. Shah N.J., Suhagia B.H., Shah R.R. and Shah P.B., 2007., Development and Validation of a HPTLC method for the simultaneous estimation of Telmisartan and Hydrochlorthiazide in tabletdosage form., Indian J Pharm Sci., 69:202-205.
8. Kabra V., Agrahari V. and Trivedi P. 2009., Development and Validation of a Reverse Phase Liquid Chromatographic Method for quantitative estimation of Telmisartan in human plasma.,13th international conference on Biomedical Engineering., 23:1297-1300.
9. Wankhede S.B., Tajne M.R., Gupta K.R. and Wadodkar S.G., 2007., RP-HPLC method for simultaneous estimation of Telmisartan and Hydrochlorothiazide in tablet dosage form., Scientific Publication of the Indian Pharmaceutical Association., 69(2):298-300.
10. Palled M.S., Chatter M., Rajesh P.M.N and Bhatt A.R., 2006., Difference spectrophotometric determination of Telmisartan in tablet dosage forms. Scientific Publication of the Indian Pharmaceutical Association.,68(5):685-686.
11. Kurade V.P., Pai M.G. and Gude R. 2009., RP-HPLC estimation of Ramipril and Telmisartan in tablets. Indian J Pharm Sci., 71(2): 148-151.